[go: up one dir, main page]

AU2002219046A1 - Regulation of human ceruloplasmin-like protein - Google Patents

Regulation of human ceruloplasmin-like protein

Info

Publication number
AU2002219046A1
AU2002219046A1 AU2002219046A AU1904602A AU2002219046A1 AU 2002219046 A1 AU2002219046 A1 AU 2002219046A1 AU 2002219046 A AU2002219046 A AU 2002219046A AU 1904602 A AU1904602 A AU 1904602A AU 2002219046 A1 AU2002219046 A1 AU 2002219046A1
Authority
AU
Australia
Prior art keywords
protein
regulation
human ceruloplasmin
ceruloplasmin
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002219046A
Inventor
Zhimin Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2002219046A1 publication Critical patent/AU2002219046A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0091Oxidoreductases (1.) oxidizing metal ions (1.16)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/90283Oxidoreductases (1.) acting on superoxide radicals as acceptor (1.15)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/906Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002219046A 2000-10-24 2001-10-22 Regulation of human ceruloplasmin-like protein Abandoned AU2002219046A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24242600P 2000-10-24 2000-10-24
US60/242,426 2000-10-24
US31379601P 2001-08-22 2001-08-22
US60/313,796 2001-08-22
PCT/EP2001/012158 WO2002034920A2 (en) 2000-10-24 2001-10-22 Regulation of human ceruloplasmin-like protein

Publications (1)

Publication Number Publication Date
AU2002219046A1 true AU2002219046A1 (en) 2002-05-06

Family

ID=26935082

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002219046A Abandoned AU2002219046A1 (en) 2000-10-24 2001-10-22 Regulation of human ceruloplasmin-like protein

Country Status (2)

Country Link
AU (1) AU2002219046A1 (en)
WO (1) WO2002034920A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013091008A1 (en) * 2011-12-20 2013-06-27 The Mental Health Research Institute Of Victoria Method of treating reduced ceruloplasmin functionality in the central nervous system
KR20240159714A (en) * 2023-04-27 2024-11-06 국립해양생물자원관 Composition for preventing or treating neurological disorders related to copper metabolism comprising improved peptide of multicopper oxidase active domain
CN118715208A (en) * 2023-10-20 2024-09-27 广东工业大学 Specific quadridentate copper chelators for the treatment of Wilson's disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2218200A1 (en) * 1996-12-09 1998-06-09 Samuel David Gpi-ceruloplasmin, analogs thereof, and methods of use
CA2283299A1 (en) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
EP1666495A1 (en) * 1999-12-01 2006-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20070087342A1 (en) * 2000-01-14 2007-04-19 Incyte Corporation Secreted proteins

Also Published As

Publication number Publication date
WO2002034920A2 (en) 2002-05-02
WO2002034920A3 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
AU2001289864A1 (en) Regulation of human protein disulfide isomerase-like enzyme
AU6604901A (en) Regulation of human hm74-like g protein coupled receptor
AU2001246526A1 (en) Regulation of human hm74-like g protein coupled receptor
AU2001254790A1 (en) Regulation of human cyslt2-like gpcr protein
AU2001281950A1 (en) Regulation of human thimet oligopeptidase-like enzyme
AU2002219046A1 (en) Regulation of human ceruloplasmin-like protein
AU2002215956A1 (en) Regulation of human pgc-1-like protein
AU2002231620A1 (en) Regulation of human patched-like protein
AU2001244205A1 (en) Regulation of human p2y-like gpcr protein
AU2001274080A1 (en) Regulation of human transketolase-like enzyme
AU2002237225A1 (en) Regulation of human patched-like protein
AU2002219083A1 (en) Regulation of human oat-like protein
AU2002218196A1 (en) Regulation of human adam-ts-like protein
AU2001263814A1 (en) Regulation of human oatp2-related protein
AU2001262133A1 (en) Regulation of human nedd1-related protein
AU2001269095A1 (en) Regulation of human caspase-1-like protease
AU2002247691A1 (en) Regulation of human elongase hselo1-like protein
AU2002308267A1 (en) Regulation of human icos v protein
AU2001293780A1 (en) Regulation of human protein phosphatase iic-like enzyme
AU2001293839A1 (en) Regulation of human fgd1-like protein
AU2001254740A1 (en) Regulation of human tap-related protein
AU2002235748A1 (en) Regulation of human patched-like protein
AU2001285782A1 (en) Regulation of human phosphodiesterase-like enzyme
AU2001281969A1 (en) Regulation of human carboxylesterase-like enzyme
AU2002210525A1 (en) Regulation of human phospholipase-like enzyme